Tagged with FEC

Thomas Lingelbach – CEO and Member of the Board of Directors, Valneva
Generalized Cost-Effectiveness Analysis (GCEA) Framework to Assess the Value of Innovative Therapies
Jürg Utzinger – Director, Swiss Tropical and Public Health Institute (Swiss TPH)
HIV Snapshot 2023
Nicoletta Luppi, Senior VP & Managing Director – MSD Italia
Sarthak Das, CEO, Asia Pacific Leaders Malaria Alliance
Marc Ayers – CEO, Romark Puerto Rico
Data for Safer Care: AI in Healthcare-Associated Infections
Janet Hoogstraate – Chair of the Management Board, Valneva Sweden
Chang Yi Wang – Chairperson and Chief Scientific Officer (CSO), United BioPharma, Taiwan
Infectious Diseases in Thailand: Spearheading a Regional Approach
Kumthorn Malathum – President, Infectious Disease Association of Thailand
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here